For the gift, start research and development of graphene batteries

Chapter 138
It was based on what happened last time that Aisif was particularly worried about the anti-tumor pure Chinese medicine of Xiayi Group.

To say that in the past, Xia Medical Group used Western medicine, Esfu felt a little disdainful, even after Xia Medical Group launched several anti-tumor drugs.

Therefore, Esif knows that under the same technical route, their Nahua Group will always have an advantage. Hundreds of years of technology has accumulated here, and it is not something you can surpass if you want to.

Especially this time, Xiayi Group's pure Chinese medicine platform has a recognition rate of more than 70%. If Xiayi Group is not lying, then this kind of breakthrough is really terrible.

Thinking of this, Asif called Stephen, the chief expert of Noah Group, over.

"Steve, this is news from our competitor, what do you think?"

Asif said straight to the point.

"To be honest, I don't really understand."

Steve frowned for a long time, and finally said this.

"I don't quite understand, I don't understand what you mean."

Asif asked.

This was the first time Esif saw that embarrassing look on Steve's face.

"Let's put it this way, the bulletin, at first glance, was so unbelievable that we subconsciously thought it was fake."

"However, as a listed company, the information disclosure is very rigorous. Even if there are some exaggerations, it is impossible to say that there are things that do not exist."

"Therefore, there must be anti-tumor drugs of this kind of pure Chinese medicine, but the information in the circular is not so credible to what extent it has progressed."

"In other words, Xia Medical Group, what are they hiding? Otherwise, they might be so high-profile. You must know that in the past, Xia Medical Group was very cautious about its own technology. Different from our concept of openness, communication, and complementarity, they Advocating self-study, self-exploitation, like to be closed."

Steve said.

"You mean, this drug may be the bait released, and they may be researching some special drug? Or is this drug itself particularly magical?"

Asif asked.

"It's very possible. But the information they disclosed is too little. It would be great if there was more."

Steve said so.

"It's simple. No matter what, we can't allow them to monopolize the benefits in the stock market regarding the information disclosure of Xia Medical Group."

Asif said.

After all, after the information was disclosed this time, affected by the good news, the share price of Xia Medical Group rose sharply.

It stands to reason that this kind of operation is what international giants like them are good at doing, but this time Xiayi Group took the lead, and Esfu was also a little upset.

"Tomorrow, I will arrange to release the news. Our latest anti-tumor drug will also be arranged to appear."

Asif said.

"Is it so urgent? According to our model, the profit of existing drugs has not yet reached its peak, and it will take about three years. Launching it so early will have an impact on our profit!"

Steve said so.

Indeed, although many of the drugs have been successfully researched, they have been kept secret from the outside world. Only after the sales peak of the previous drug has passed, the new drug will be released simultaneously to continue the former's responsibilities.

This is the model that Noah Group hired a famous economist to predict.

Not to mention, after using this model, Noah Group's turnover has been rising in a straight line, and shareholders are extremely satisfied.

To change this rule now is undoubtedly breaking the previous style of conduct. Without sufficient reasons, shareholders will not agree.

Thinking of the shareholders' clampdown on him, Esif was also a little worried.

"Since the reasons are not sufficient, then we will do enough. Isn't Xia Yi Group pushing the platform of pure Chinese medicine, we will vigorously promote it, and we will promote it high. In this case, I don't believe it. Shareholders will sit and wait."

Asif thought gloomily.

"Besides, as the saying goes, the higher the praise, the harder the fall. I don't believe that Xia Medical Group can maintain this situation. The cowhide will always break one day. At present, this process should be shortened as much as possible."

It has to be said that Esif is very good at engaging in business competition.

In a short period of time, a whole set of combined punches was formed, intending to knock down the Xia Medical Group.

It's just that the result will be as he predicted, not necessarily!

With the operation of Noah Group, the research on Xiayi Group's pure traditional Chinese medicine anti-tumor drugs has become more and more popular in the whole market.

First of all, the famous international magazine Meimeidao reproduced the research statement about Xiayi Group, and claimed that the research of Xiayi Group is of great significance in promoting the progress of medicine.

Xia Medical Group created a precedent for anti-tumor drugs.

You know, the eyebrow trimming knife magazine, as the top journal in the medical field, is very authoritative in medicine.

For the review of manuscripts, it is quite cautious.

Especially the manuscripts aimed at Xia Guo scholars and companies are even more cautious.It is unusual to report on the achievements of Xiayi Group in anti-tumor drugs this time.

Could it be that Xia Medical Group has really made a major breakthrough in this regard.

As for the technical strength of Xia Medical Group, it does have it, but whether it can deserve this kind of praise is something to consider.

The report of the eyebrow trimming knife magazine was just the beginning. Next, a series of issues and magazines followed up the report of the Xia Medical Group, and the Xia Medical Group instantly became popular.

With the crazy reports of foreign media, Xiaguo Enterprise also followed up.

Over the years, foreign pharmaceutical companies have been the mainstream, and they have been wildly praised. Xia Guo's companies have never received such treatment.

Xia Guo's official media is still relatively restrained, reporting the attention of foreign media and the contribution of Xia Medical Group in the pharmaceutical industry in a relatively objective manner.

Among them, some praise is inevitable.

But overall, not too exaggerated.

But many self-media in China, in order to gain traffic, are not so polite, how exaggerated, how come.

Shock!Xia Medical Group's move shocked the western medical community!
Pure traditional Chinese medicine anti-tumor drugs are going to the market, and the tumor sheds tears when it sees it!
Pure Chinese medicine anti-tumor drugs cured my cancer, a confession of a cancer patient.

Pure herbs, no side effects, strong curative effect, the story that Xia Medical Group and I have to tell.

All of a sudden, all kinds of exaggerated headlines filled the entire news media, making people dazzled.

It was as if Xia Medical Group had become a holy place for anti-tumor drugs in an instant.

Not only the practitioners of medical professionals are stunned, but ordinary people are also a little at a loss when they see this kind of news. What happened?

It's a bit unscientific for Xia Medical Group to be so arrogant in such a short period of time.

Xia Medical Group, General Manager Office.

Shi Meisheng looked at the news reports and was also a little confused.

What did I do, I just sent a letter of information disclosure as required, how did I make the whole market go uproar.

And what's the matter with the eyebrow trimming knife magazine, how could it kindly report the statement of Xia Medical Group.

You must know that in the past, the research results of the Zhenger Bajing of the Xia Medical Group submitted eyebrow trimmers and submitted manuscripts for publication many times, but they were all rejected.

It's not that the innovation ability is insufficient, it means that the experimental conclusion lacks basis.

In short, there are very few articles that can be published on eyebrow trimming knife.

The abnormality this time caused many people to ask whether the Xia Medical Group and the eyebrow trimming knife magazine have been linked online, or whether the Xia Medical Group has invested in the eyebrow trimming knife, otherwise it would be impossible to be so popular.

In just two short days, Shi Meisheng has already received many phone calls, and many people want Shi Meisheng to help introduce him.

It was impossible to recommend, because Shi Meisheng didn't even know what kind of madness the eyebrow trimming knife magazine was going on.

And Qi Shi Meisheng also asked specifically, Xia Medical Group did not carry out research work on eyebrow trimming knife magazine, it was still the same as before.

Therefore, Shi Meisheng is also in a state of confusion.

After this news report, Xia Medical Group became more popular.Affected by this news, the share price of Xia Medical Group rose sharply.

Seeing this, shareholders are delighted.

Of course, the Xia Guo government is the largest shareholder, and there will be no such move as selling, and the impact will not be great.

However, being famous also comes at a price. Regarding the joint development of new drugs, more and more companies have come to ask for cooperation.Shi Meisheng felt a little rushed.

More importantly, Xia Medical Group has no finished products to sell now.

Although the spirit chasing project has made significant progress, it will take some time before it can be successfully developed.

It's now like a new product launch conference.

Under this pressure, Shi Meisheng issued an order to speed up the progress of the project and successfully develop the chasing spirit project in the shortest possible time.

But research and development takes time, and it's not just an order.

In this regard, Shi Meisheng had no choice but to release some information to calm the market's expectations.

In this way, Xia Medical Group releases a small amount of information every once in a while.

Under the pursuit of the market, the popularity is very high.

Well, the group is holding a general meeting of shareholders.

Recently, there have been rumors that Xia Medical Group's anti-tumor drugs will compete head-on with Noah Group.

There are rumors that pure Chinese medicine anti-tumor drugs will be the focus of research in the next stage, and traditional anti-tumor drugs will completely become history.

It's spread in style, and if you watch it too much, it's really easy to shake people.

In particular, Xia Medical Group's practice of announcing the progress of the project every once in a while has maintained this enthusiasm.

If things go on like this, Asif is a little skeptical whether the focus of the next stage of anti-tumor drugs is really pure Chinese medicine.

The work at this stage is a bit in vain.

Under the influence of this concept in the market, Nahua's stock price began to decline slowly.Although the decline is not much, but the trend has been obvious.

If there is no new news that can cheer investors up, the stock price will maintain a downward trend.

The emergence of this situation was also unexpected by Esfu.

I just want to put some pressure on the Xia Medical Group and let the public expose the lies of the Xia Medical Group. How did it become like this?

How high was the agreed Peng, how hard did the fall fall?
Seeing that the Xia Medical Group now treats the research and development of pure traditional Chinese medicines as a fan circle culture, and has quickly accumulated some fans, Esif also feels a little speechless.

Because according to this way of playing, Xia Medical Group can play the game for a long time.

After a long time, the onlookers may not be able to bear the end of the show, and after the market heat naturally drops, they will have nothing to do with the company.

After that, who will pay attention to this matter?
No matter what happened to Xia Medical Group, Esif felt that measures had to be taken to regain confidence in the market.

From the anxious expressions of the shareholders at the shareholders meeting, Esif felt that his plan to promote the launch of new drugs had been achieved.

Every time a new drug is launched, it is a time when various interests are redistributed.

This time, take the opportunity to keep some resources firmly in your hands.

This is Asif's plan.

"Everyone, what I want to say is that Xia Medical Group's new drug has a great impact on us, and it has a great blow to the confidence of the entire market. It's time to launch a new product."

Asif revealed his plan.

"Aisif, according to your assessment, can Xiayi Group's pure Chinese medicine anti-tumor drug be successfully researched?"

A representative of a major shareholder asked this question.

They want to determine the threat of Xiayi Group's products.

Although the news from the outside is overwhelming and the spread is miraculous, but the specific situation needs to be clarified by insiders.

After all, according to the plan, new products should not be introduced to the market at this time.

Doing so will definitely have an impact on the interests of the Noah Group this year.

Because the launch of a new product requires preheating, publicity, massive publicity and distribution costs, and reorganization of channels.

Everything costs money.

Before uncertainty, it is most beneficial to maintain the current situation.

"According to our team's analysis, it is possible."

"However, we don't know how sure it is. After all, according to Xia Medical Group, this is a pure Chinese patent medicine, which is very different from our previous research route."

"This kind of pure Chinese anti-tumor drug has never appeared on the market. It can be said that it is a pioneering progress, regardless of whether they can succeed in research."

Facing the major shareholder, Esif explained the new products of Xiayi Group very objectively.

After all, this kind of shareholders meeting is very formal.

The description of the problem is required to be fair and objective, without being subjectively misleading.

If it is found out later, because the management subjectively misleads or conceals important information, the management will have to bear criminal responsibility.

The shareholders were silent for a while when they heard Esif's words.

Now it is impossible to rule out the possibility of Xia Medical Group's bluffing, but it is also impossible to be sure that the pure Zhongcheng anti-tumor drug will be successfully developed soon.

It is not even known whether its specific efficacy can meet the needs of the market.

They need to make the best investment judgment in various opaque environments.

To be honest, it's hard!

(End of this chapter)